The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine: A postmarketing assessment

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 5, 1996, Pages 457-460

  Rosenthal, Steven ^a,b   Chen, Robert ^a   Hadler, Stephen ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b Box 7 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; PERTUSSIS VACCINE; TETANUS TOXOID;

APNEA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DRUG FORMULATION; DRUG SAFETY; FEVER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEIZURE; SOMNOLENCE; TREMOR; VACCINATION; VOMITING;

CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INFANT; MALE; PERTUSSIS VACCINE; PRODUCT SURVEILLANCE, POSTMARKETING; SEIZURES; UNITED STATES; VACCINES, COMBINED;

EID: 0029874592     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170300011001     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Food and Drug Administration approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 1991;40:881-882.
2. Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series: update to supplementary ACIP statement. MMWR Morb Mortal Wkly Rep. 1992;41 (RR-15):1-5.
3. Mortimer EA, Kimura M, Cherry JD, et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. AJDC. 1990;144:899-904.
4. Marwick C. Changes ahead in childhood immunization. JAMA. 1996;275:582.
5. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press; 1991.
6. Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use: supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1992;41(RR-1):1-10.
7. Black S, Shinefield H, Lewis N, Ray P, Hiatt R, Fireman B. Decreased local/ systemic side effects and emergency room utilization following dPDT in toddlers and preschoolers when compared with wDTP. Pediatr Res. 1993;33: 163A. Abstract.
8. Chen RT. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, England: John Wiley & Sons Ltd; 1994:581-594.
9. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12:542-550.
10. Centers for Disease Control and Prevention. Adverse Events Following Immunization Surveillance Report No. 3, 1985-1986. Atlanta, Ga: Centers for Disease Control and Prevention: February 1989.
11. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubelia immunization. Pediatrics. 1991;88:881-885.
12. Pollock TM, Morris J. A seven-year survey of disorders attributed to vaccination in North West Thames Region. Lancet. 1983;1:753-757.
13. Laboratory Centre for Disease Control. Proceedings of a Workshop on the Standardization of Definitions lor Post-Marketing Surveillance of Adverse Vaccine Reactions, Ottawa, Canada, October 30-31, 1991. Ottawa, Ontario: Laboratory Centre for Disease Control; 1991:1-17.
14. Cherry JD. The epidemiology of pertussis and pertussis vaccine in the United Kingdom and the United States: a comparative study. Curr Probt Pediatr. 1984; 14:1-78.
15. Kanal K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Sci Biol. 1980;33:107-143.
16. Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J. 1987;6:664-671.
17. 42 US Code, Sec 300aa-28.
18. Kate T, Goshima T, Nakajima N, et al. Protection against pertussis vs acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan. Acta Paediatr Jpn. 1989;31:698-701.